Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
39.57-0.34 (-0.85%)
At close: 04:00PM EDT
39.57 0.00 (0.00%)
After hours: 04:16PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Performance Outlook
Previous Close39.91
Open39.91
Bid39.04 x 1300
Ask39.66 x 1300
Day's Range39.29 - 40.18
52 Week Range29.85 - 59.46
Volume511,988
Avg. Volume997,011
Market Cap5.22B
Beta (5Y Monthly)1.24
PE Ratio (TTM)23.14
EPS (TTM)1.71
Earnings DateNov 06, 2023 - Nov 10, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est51.80
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
64% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HALO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Halozyme Therapeutics, Inc.
    HALO: Rating increased to a BUYHALOZYME THERAPEUTICS INC has an Investment Rating of BUY; a target price of $39.000000; an Industry Subrating of Medium; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    10 days agoArgus Research
View more
Advertisement
Advertisement